We also observed a radiosensitization of talazoparib, a PARP1/2 inhibitor, in two of our HNSCC cell lines, similar to findings among small cell lung cancer (SCLC) and some other solid tumors27. The gene discussed is PARP1; the disease is head and neck squamous cell carcinoma.